National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening
A Farkas, D Schneider, M Perrotti, KB Cummings… - Urology, 1998 - Elsevier
Objectives. The use of prostate-specific antigen (PSA) to screen for prostate cancer remains
controversial. Although it is still too early to measure directly the effects of PSA screening on …
controversial. Although it is still too early to measure directly the effects of PSA screening on …
National trends in the epidemiology of prostate cancer, 1973 to 1994: Evidence for the effectiveness of prostate-specific antigen screening
A Farkas, D Schneider, M Perrotti, KB Cummings… - …, 1998 - researchwithrutgers.com
Objectives. The use of prostate-specific antigen (PSA) to screen for prostate cancer remains
controversial. Although it is still too early to measure directly the effects of PSA screening on …
controversial. Although it is still too early to measure directly the effects of PSA screening on …
[引用][C] National trends in the epidemiology of prostate cancer, 1973 to 1994: Evidence for the effectiveness of prostate-specific antigen screening
A FARKAS - Urology, 1998 - cir.nii.ac.jp
National trends in the epidemiology of prostate cancer, 1973 to 1994 : Evidence for the
effectiveness of prostate-specific antigen screening | CiNii Research CiNii 国立情報学研究所 …
effectiveness of prostate-specific antigen screening | CiNii Research CiNii 国立情報学研究所 …
National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening-on the down side of a …
A Farkas, D Schneider, M Perrotti, KB Cummings… - Urology, 1998 - infona.pl
Objectives. The use of prostate-specific antigen (PSA) to screen for prostate cancer remains
controversial. Although it is still too early to measure directly the effects of PSA screening on …
controversial. Although it is still too early to measure directly the effects of PSA screening on …
[PDF][PDF] NATIONAL TRENDS IN THE EPIDEMIOLOGY OF PROSTATE CANCER, 1973 TO 1994: EVIDENCE FOR THE EFFECTIVENESS OF PROSTATE-SPECIFIC …
A FARKAS, D SCHNEIDER, M PERROTTI… - UROLOGY, 1998 - researchgate.net
Objectives. The use of prostate-specific antigen (PSA) to screen for prostate cancer remains
controversial. Although it is still too early to measure directly the effects of PSA screening on …
controversial. Although it is still too early to measure directly the effects of PSA screening on …
[引用][C] National trends in the epidemiology of prostate cancer, 1973 to 1994: Evidence for the effectiveness of prostate-specific antigen screening. Commentary …
A FARKAS, D SCHNEIDER… - Urology …, 1998 - pascal-francis.inist.fr
National trends in the epidemiology of prostate cancer, 1973 to 1994 : Evidence for the
effectiveness of prostate-specific antigen screening. Commentary. Author's reply CNRS Inist …
effectiveness of prostate-specific antigen screening. Commentary. Author's reply CNRS Inist …
National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening
A Farkas, D Schneider, M Perrotti, KB Cummings… - Urology, 1998 - goldjournal.net
Objectives. The use of prostate-specific antigen (PSA) to screen for prostate cancer remains
controversial. Although it is still too early to measure directly the effects of PSA screening on …
controversial. Although it is still too early to measure directly the effects of PSA screening on …
National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening
A Farkas, D Schneider, M Perrotti, KB Cummings… - …, 1998 - pubmed.ncbi.nlm.nih.gov
Objectives The use of prostate-specific antigen (PSA) to screen for prostate cancer remains
controversial. Although it is still too early to measure directly the effects of PSA screening on …
controversial. Although it is still too early to measure directly the effects of PSA screening on …
[PDF][PDF] NATIONAL TRENDS IN THE EPIDEMIOLOGY OF PROSTATE CANCER, 1973 TO 1994: EVIDENCE FOR THE EFFECTIVENESS OF PROSTATE-SPECIFIC …
A FARKAS, D SCHNEIDER, M PERROTTI… - UROLOGY, 1998 - academia.edu
Objectives. The use of prostate-specific antigen (PSA) to screen for prostate cancer remains
controversial. Although it is still too early to measure directly the effects of PSA screening on …
controversial. Although it is still too early to measure directly the effects of PSA screening on …
National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening.
A Farkas, D Schneider, M Perrotti, KB Cummings… - Urology, 1998 - europepmc.org
Objectives The use of prostate-specific antigen (PSA) to screen for prostate cancer remains
controversial. Although it is still too early to measure directly the effects of PSA screening on …
controversial. Although it is still too early to measure directly the effects of PSA screening on …